Does Kaiser Permanente Cover Victoza?
The verdict
Conditional on most plans
Kaiser Permanente covers Victoza (liraglutide) for type 2 diabetes with prior authorization — it is not covered for weight loss. As a closed-network HMO, Kaiser's own formulary and P&T committee determine your actual access. Brand Victoza is now commonly stepped toward the authorized generic liraglutide (Teva, June 2024), so 'does Kaiser cover Victoza' often resolves to 'Kaiser covers liraglutide and you'll likely fill the generic.' Do not confuse Victoza with Saxenda — same molecule, different indication.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Kaiser Permanente using your member ID.
Key facts
Generic liraglutide (authorized generic, Teva, June 2024) is now available and approximately $470 for a 2-pack — as low as $144–$234/month with coupons — and Kaiser increasingly dispenses it in place of brand Victoza.
Drugs.com cash price reference
Victoza (liraglutide 0.6–1.8mg) is FDA-approved for type 2 diabetes and CV risk reduction — not for weight loss. Saxenda (liraglutide 3.0mg) is the weight-loss form and follows different coverage rules.
FDA Prescribing Information, liraglutide (Victoza and Saxenda)
Medi-Cal excludes weight-loss drugs effective 1/1/2026, but this does not affect Victoza's diabetes coverage — it targets weight-loss GLP-1s like Saxenda.
California Medi-Cal formulary guidance, 2026
Medicare vs. commercial coverage
Whether Kaiser Permanente covers Victoza depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Kaiser Medicare Part D covers Victoza/liraglutide for type 2 diabetes (ICD-10 E11.x) with prior authorization. Kaiser Medicare plans step toward generic liraglutide (Teva authorized generic) where available. Specialty/brand tier with 25% coinsurance; continuous users can reach the 2026 $2,100 Part D annual OOP cap within a few months. Victoza is NOT covered for weight loss; there is no weight-loss GLP-1 Bridge for Victoza (the Bridge covers Wegovy/Foundayo/Zepbound KwikPen only). Manufacturer savings cards are not usable for government-insured members; the generic is the main cost lever for Kaiser Medicare patients.
Commercial / Employer
Group & marketplace plans
Kaiser commercial/employer HMO plans cover Victoza for type 2 diabetes and CV risk reduction with prior authorization. Kaiser is a closed-network HMO — you receive whichever liraglutide product Kaiser's P&T committee prefers, and the generic liraglutide (Teva, June 2024) at a lower cost is increasingly what Kaiser dispenses. ACA/individual Kaiser plans cover for diabetes only. Medi-Cal (Kaiser's California Medicaid line) excludes weight-loss drugs effective 1/1/2026 — this is relevant only to distinguish Victoza's diabetes coverage from Saxenda's excluded weight-loss use. Kaiser cells represent a composite; verify on Kaiser's member formulary.
The 4 boxes you must tick to get approved
Commercial plans that will consider Victoza require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Victoza actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Victoza cash price approximately $1,023–$1,440/month; Victoza 2-pen cash approximately $539 (Drugs.com). Generic liraglutide (Teva) approximately $470 for a 2-pack; as low as $144–$234/month with coupons.
List price with no coverage — before any manufacturer savings card.
With coverage
With Kaiser coverage and prior auth: cost depends on your Kaiser plan's tier for liraglutide/Victoza. The generic liraglutide (Teva) substantially reduces both list price and post-coverage cost. For Kaiser Medicare members, the 2026 $2,100 Part D OOP cap applies.
Typical monthly copay once prior authorization is approved.
Bridge program
Victoza has no $25-equivalent manufacturer savings card comparable to Lilly's Trulicity or Mounjaro card. NovoCare patient assistance (Novo Nordisk) may apply for eligible uninsured or low-income patients. Manufacturer savings exclude government-insured patients.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Verify current pricing at Kaiser's internal pharmacy and confirm whether your plan dispenses the authorized generic liraglutide.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search Kaiser's member formulary
Log in at kp.org and search for 'liraglutide' or 'Victoza' to confirm whether Kaiser's formulary lists brand Victoza or the generic, your plan's tier, and PA requirements. Kaiser is a closed-network HMO; you fill at Kaiser's internal pharmacy.
- 2
Clarify the brand vs. generic liraglutide question
Ask your Kaiser provider whether they will prescribe brand Victoza or generic liraglutide (Teva authorized generic, June 2024). If Kaiser's formulary requires the generic, brand Victoza may not be dispensed even with a valid PA for the brand. Same molecule, lower cost.
- 3
Have your prescriber submit the prior authorization with T2D diagnosis
Your doctor submits the PA coded with ICD-10 E11.x (type 2 diabetes), not E66.x (obesity). Do not confuse Victoza with Saxenda — they are different products even though both are liraglutide. Kaiser's internal clinical teams process the PA.
Options if Kaiser Permanente won't cover Victoza
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic liraglutide (Teva, 2024)
The authorized generic of Victoza at a substantially lower price. Kaiser may dispense this in place of brand Victoza. Same active molecule.
Ozempic (semaglutide)
Another GLP-1 FDA-approved for type 2 diabetes. Kaiser often positions semaglutide in its tier structure; check Kaiser's formulary for preferred drug.
Saxenda (liraglutide 3.0mg)
The weight-loss form of liraglutide — FDA-approved for chronic weight management, not diabetes. Follows AOM coverage logic (exclusion risk, BMI-based PA). Do not confuse with Victoza.
Compounded semaglutide or tirzepatide (via Curex)
A weight-management option that does not require insurance or prior authorization. Not the same medication as Victoza.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Kaiser's P&T committee increasingly prefers the authorized generic liraglutide (Teva, June 2024) over brand Victoza. In a closed-network HMO, you fill at Kaiser's pharmacy and receive what Kaiser's formulary specifies. Your doctor may write for Victoza, but Kaiser may dispense the generic. This is not a problem — it is the same molecule (liraglutide) at a meaningfully lower cost. Confirm with your Kaiser provider and the member formulary.
No. Victoza (liraglutide 0.6–1.8mg) is FDA-approved for type 2 diabetes and cardiovascular risk reduction — it has no weight-loss indication. Kaiser will not cover Victoza for obesity. Requests coded with E66.x are denied. The weight-loss form of liraglutide is Saxenda (liraglutide 3.0mg), which follows a completely different AOM/weight-loss coverage pathway at Kaiser, and Medi-Cal excludes weight-loss drugs effective 1/1/2026.
Victoza (liraglutide 0.6–1.8mg) is FDA-approved for type 2 diabetes and cardiovascular risk reduction. Saxenda (liraglutide 3.0mg) is the same molecule at a higher dose and is FDA-approved for chronic weight management — an entirely different indication. Kaiser treats them completely differently: Victoza follows the diabetes coverage track; Saxenda follows the weight-loss/AOM track and is subject to exclusion under benefit carve-outs and standard Medicare Part D.
Medi-Cal effective 1/1/2026 excludes weight-loss drugs — this is relevant context but does not affect Victoza's diabetes coverage. Victoza is a diabetes drug and is covered for T2D with prior authorization on Medi-Cal, separate from the weight-loss exclusion. The 1/1/2026 Medi-Cal restriction eliminates coverage for weight-loss GLP-1s like Saxenda, not for diabetes GLP-1s like Victoza.
Kaiser typically requires: confirmed type 2 diabetes (ICD-10 E11.x), recent A1c documentation, and a metformin trial or contraindication. Kaiser may also step you to the generic liraglutide (Teva) if the formulary prefers it over brand Victoza. All figures are composites based on Kaiser P&T guidance; verify on your specific Kaiser region's formulary for exact requirements.
Related Articles
Does Kaiser Permanente Cover Vyvanse? | Curex
Kaiser Permanente covers Vyvanse on its closed formulary via Kaiser pharmacies — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL.
Read moreDoes Kaiser Permanente Cover Qsymia? 2026 | Curex
Kaiser's closed HMO limits Qsymia access; Medi-Cal excluded weight-loss drugs in 2026. Engage cash program ~$89/mo; generic launched 2025.
Read moreDoes Kaiser Permanente Cover Cialis? 2026 | Curex
Kaiser Permanente does not cover Cialis for ED — Medicare Part D bars it by law and commercial plans exclude it. Generic tadalafil IS covered for BPH.
Read moreDoes Kaiser Permanente Cover Jardiance? 2026
Kaiser Permanente covers Jardiance on its closed-network formulary for T2D. Metformin-first step may apply. 2026 MFP $197; $2,100 cap for Medicare.
Read moreDoes Kaiser Permanente Cover Ozempic? 2026 Guide | Curex
Kaiser NW covers Ozempic for T2D — requires metformin plus SGLT-2 step therapy, strictest in the cluster. Tier 3, closed network, weight-loss excluded.
Read moreDoes Kaiser Permanente Cover Viagra? 2026 Guide
Kaiser Permanente does not cover Viagra for ED. The Medicare Part D statutory exclusion applies. Only covered path: sildenafil (Revatio) for PAH.
Read moreA weight-management path that skips insurance and prior auth
Curex offers compounded semaglutide from $49/month and compounded tirzepatide from $149/month at getcurex.com/cl/glp — no insurance and no prior authorization required. This is compounded semaglutide/tirzepatide and is not the same medication as Victoza. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Victoza and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Kaiser Permanente before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Victoza and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.